FindTrial
Sign In

A Long-Term Follow-Up Study Evaluating the Efficacy and Safety of ZOC2017217 in Patients with Age-Related Cataract After Treatment Completion

A Long-Term Follow-Up Study Evaluating the Efficacy and Safety of ZOC2017217 in Patients with Age-Related Cataract After Treatment Completion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129698
Enrollment
Unknown
Registered
2026-08-07
Start date
2026-08-15
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related cataract

Interventions

0.4% BID group:NA
0.2% TID group:NA
0.4% TID group:NA
Placebo group:NA

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Subjects who voluntarily participate, provide written informed consent, and are able to comply with scheduled follow-up visits; 2.Patients with age-related cataract who have completed at least 12 weeks of treatment in the GOCS-H101-E05 clinical study;

Exclusion criteria

Exclusion criteria: 1.Subjects who have undergone cataract surgery in the study eye. 2.Patients who are unable to continue long-term follow-up due to other diseases. 3.Subjects who, in the investigator’s judgment, have conditions that may affect compliance or are otherwise unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Adverse Event (AE) / Serious Adverse Event (SAE) Incidence;Computerized auto-refraction;Visual Function Questionnaire;Contrast sensitivity;Visual acuity assessment;—

Countries

China

Contacts

Public ContactZou Haidong

Shanghai General Hospital

zouhaidong@sjtu.edu.cn+86 21 63240090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026